logo

For the Inventor, By the Inventor

Tsukuba, Japan

Motoaki Nishikawa

This inventor holds 5 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1986-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoaki Nishikawa. Retrieved from https://idiyas.com/inventor/motoaki-nishikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Toyonaka, JP (1986 - 1987)
  • Tsukuba, JP (1993 - 1995)

Company Filing History:

goldMedal5 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1986-1995

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5436140 - Process for producing WS-9326A and WS-9326B (1995-07-25),
2. 5217952 - Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof (1993-06-08),
3. 5187195 - Anthraquinone derivatives and preparation thereof (1993-02-16),
4. 4661352 - WS 7739 substances, their preparation and pharmaceutical composition (1987-04-28),
5. 4578271 - Biologically active WS 6049 substances, a process for the production (1986-03-25),

Title: The Innovations of Motoaki Nishikawa

Introduction

Motoaki Nishikawa is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative work on novel peptides. With a total of 5 patents to his name, Nishikawa's inventions focus on treatments for asthma and pain.

Latest Patents

Nishikawa's latest patents include a process for producing WS-9326A and WS-9326B. These novel peptides, along with their derivatives and pharmaceutically acceptable salts, exhibit useful pharmacological activities, especially in the treatment and prevention of asthma and pain. The method for producing these peptides utilizes Streptomyces violaceoniger No. 9326 in a biologically pure form. Another significant patent relates to the peptides WS-9326A and WS-9326B, their derivatives, and their uses, emphasizing their pharmacological benefits.

Career Highlights

Motoaki Nishikawa is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the company's portfolio but has also had a broader impact on medical treatments available for patients.

Collaborations

Nishikawa has collaborated with notable colleagues such as Sumio Kiyoto and Shigehiro Takase. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Motoaki Nishikawa's contributions to the field of pharmacology through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the development of effective treatments for asthma and pain.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…